Compare FCNCP & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCNCP | SHC |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | 18141 | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 4.4B |
| IPO Year | N/A | 2020 |
| Metric | FCNCP | SHC |
|---|---|---|
| Price | $20.08 | $15.63 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $20.33 |
| AVG Volume (30 Days) | 7.6K | ★ 3.9M |
| Earning Date | N/A | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | N/A | $7.51 |
| Revenue Next Year | N/A | $6.00 |
| P/E Ratio | ★ N/A | $175.06 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $19.97 | $10.80 |
| 52 Week High | $22.86 | $19.85 |
| Indicator | FCNCP | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 31.33 | 51.81 |
| Support Level | $20.03 | $15.16 |
| Resistance Level | $21.33 | $16.48 |
| Average True Range (ATR) | 0.23 | 0.43 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 10.82 | 55.07 |
First Citizens is a US regional bank with total assets of around $236 billion as of March 31, 2026. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of acquiring troubled banks from the FDIC, such as Silicon Valley Bridge Bank in 2023, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing in 2025.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.